A novel extract SB-300 from the stem bark latex of Croton lechleri inhibits CFTR-mediated chloride secretion in human colonic epithelial cells

Journal of Ethnopharmacology
Horst FischerBeate Illek

Abstract

An oligomeric proanthocyanidin (SP-303) extracted from the bark latex of the tree Croton lechleri (family Euphorbiaceae) is a potent inhibitor of cholera toxin-induced fluid accumulation and chloride secretion. The manufacturing process for SP-303 was optimized and simplified to produce an increased yield of the herbal extract. The novel extract (named SB-300) contained on average 70.6+/-7.2% SP-303 by weight (mean +/- S.D.; n=56 lots). Here, we describe the effectiveness of SB-300 on cAMP-regulated chloride secretion, which is mediated by the cystic fibrosis transmembrane conductance regulator Cl- channel (CFTR) in human colonic T84 cells. Exposure of the apical surface to SB-300 blocked forskolin-stimulated Cl- secretion by 92.2+/-3.0% with a half-maximal inhibition constant (KB) of 4.8+/-0.8 microM. For SP-303, stimulated Cl- currents were decreased by 98.0+/-7.2 % and KB averaged 4.1+/-1.3 microM. There was no significant difference between the blocking kinetics of SP-303 and SB-300. Forskolin-stimulated whole cell Cl- currents were effectively blocked by extracellular addition of SB-300 (63+/-8.5%; n=3) and to a similar extent by SP-303 (83 +/- 0.6%; n=2; at 50 microM each). Both extracts inhibited a time- and voltage-inde...Continue Reading

References

Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·I CrawfordC F Higgins
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·W H Cliff, R A Frizzell
Jan 1, 1981·Annual Review of Medicine·R A Giannella
May 1, 1994·The Journal of Clinical Investigation·M E HuflejtT E Machen
Jun 16, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D S Sherman, D N Fish
Sep 1, 1994·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·R UbillasK Nakanishi

❮ Previous
Next ❯

Citations

Mar 13, 2010·Pharmaceutical Research·Nisa WongsamitkulVaranuj Chatsudthipong
Jul 27, 2005·Current Gastroenterology Reports·Timothy O Lipman
Apr 6, 2005·Trends in Pharmacological Sciences·Jay R Thiagarajah, A S Verkman
Nov 4, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Charles D Ericsson
Mar 22, 2014·Future Medicinal Chemistry·John G CummingMichael J Waring
Dec 17, 2008·Women's Health·Mopelola A Adeyemo, Lin Chang
Oct 19, 2010·Gastroenterology Clinics of North America·Alexandra J Kent, Matthew R Banks
Dec 7, 2007·Journal of Ethnopharmacology·Deepika GuptaRajinder K Gupta
Mar 18, 2010·Experimental Physiology·Michael MurekJohn Geibel
Sep 22, 2005·Journal of Ethnopharmacology·Claudia VelázquezGuillermo Ceballos
Jun 1, 2005·Pediatric Clinics of North America·Manuel R Amieva
Jan 24, 2012·Journal of Ethnopharmacology·Raquel Cássia SantosClélia Akiko Hiruma-Lima
Apr 15, 2010·The Annals of Pharmacotherapy·Rustin D CrutchleyKevin W Garey
Jul 4, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Simona De MarinoMaria Iorizzi
Jul 2, 2011·Biological & Pharmaceutical Bulletin·Qing-Zhong LiKi-Wug Sung
Dec 5, 2019·Clinical and Translational Gastroenterology·Judy NeeAnthony J Lembo
Sep 1, 2009·Current Protocols in Pharmacology·John A Beutler
Sep 28, 2013·Expert Review of Gastroenterology & Hepatology·Poorvi Chordia, Rodger D MacArthur
Sep 24, 2005·The Journal of Nutrition·Maximilian SchuierHorst Fischer
Dec 14, 2011·Expert Review of Gastroenterology & Hepatology·Jessica CottreauKevin W Garey
Feb 18, 2010·Current Protocols in Pharmacology·John A Beutler
Jul 27, 2017·Journal of Pharmaceutical Sciences·Peter A KleindlM Laird Forrest
Sep 21, 2007·Journal of Agricultural and Food Chemistry·Jaw-Chyun ChenChien-Yun Hsiang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.